{"gao_id": "GAO-11-365", "published": "2011-03-23T13:00:00Z", "released": "2011-03-23T09:00:00Z", "summary": "", "title": "End-Stage Renal Disease: CMS Should Assess Adequacy of Payment When Certain Oral Drugs Are Included and Ensure Availability of Quality Monitoring Data", "topics": ["Hospital care services", "Urologic diseases", "Payments", "Data collection", "Dialysis", "Health Care", "Prescription drugs", "Beneficiaries", "Monitoring", "Quality improvement", "Health care programs", "Pharmaceutical industry", "Cost analysis", "Disease detection or diagnosis", "Drugs", "Systems design", "Health care planning", "Medicare", "Substance abuse treatment"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-11-365", "versions": [{"title": "Highlights", "url": "https://www.gao.gov/assets/gao-11-365-highlights.pdf"}, {"title": "Full Report (44 pages)", "url": "https://www.gao.gov/assets/gao-11-365.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/a316818.html"}]}